A Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid Tumors

计划入组 400 人 · 首次发布于 2018 年 12 月 27 日

Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA

计划入组 50 人 · 首次发布于 2025 年 12 月 18 日

Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC

计划入组 50 人 · 首次发布于 2024 年 8 月 5 日

Human papillomavirus type 16 L1 capsid protein antigen(Cervarix, Gardasil, Gardasil 9)

sPD-L1

Human papillomavirus type 6 L1 capsid protein antigen(Gardasil, Gardasil 9)

ImmunoPrecise Antibodies

Canada

3D MEDICINES

Hong Kong, China

AbCellera Biologics

Biomimetic mRNA Delivery System Achieves 20-Fold Improvement in Tumor Targeting for Colorectal Cancer

Novel αPD-1-Conjugated Nanodrugs Show Promise for Overcoming Pancreatic Cancer Immunotherapy Barriers

Advancements in PD-L1 Immunohistochemistry and Digital Pathology